WallStreetZenWallStreetZen

NASDAQ: ICCM
Icecure Medical Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ICCM

Based on 1 analyst offering 12 month price targets for Icecure Medical Ltd

Min Forecast
$1.00+323.73%
Avg Forecast
$1.00+323.73%
Max Forecast
$1.00+323.73%

Should I buy or sell ICCM stock?

Based on 1 analyst offering ratings for Icecure Medical Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ICCM stock forecasts and price targets.

ICCM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-14

1 of 1

Forecast return on equity

Is ICCM forecast to generate an efficient return?

Company
77.99%
Industry
18.14%
Market
169.74%
ICCM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ICCM forecast to generate an efficient return on assets?

Company
49.8%
Industry
14.55%
ICCM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ICCM earnings per share forecast

What is ICCM's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.19
Avg 2 year Forecast
-$0.14
Avg 3 year Forecast
-$0.07

ICCM revenue forecast

What is ICCM's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$6.7M+88.5%
Avg 2 year Forecast
$13.7M+284.66%
Avg 3 year Forecast
$28.5M+698.26%
ICCM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICCM revenue growth forecast

How is ICCM forecast to perform vs Medical Devices companies and vs the US market?

Company
96.16%
Industry
8.63%
Market
13.75%
ICCM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICCM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICCM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ICCM$0.24$1.00+323.73%Strong Buy
ADGM$0.85$3.50+314.20%Strong Buy
LFWD$6.34$10.00+57.73%Buy
IRIX$1.01N/AN/A
HIND$2.23N/AN/A
View Top Medical Device Stocks

Icecure Medical Stock Forecast FAQ

Is Icecure Medical Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ICCM) stock is to Strong Buy ICCM stock.

Out of 1 analyst, 1 (100%) are recommending ICCM as a Strong Buy, 0 (0%) are recommending ICCM as a Buy, 0 (0%) are recommending ICCM as a Hold, 0 (0%) are recommending ICCM as a Sell, and 0 (0%) are recommending ICCM as a Strong Sell.

If you're new to stock investing, here's how to buy Icecure Medical stock.

What is ICCM's earnings growth forecast for 2026-2028?

(NASDAQ: ICCM) Icecure Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.48%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.

Icecure Medical's earnings in 2026 is -$15,743,000.On average, 5 Wall Street analysts forecast ICCM's earnings for 2026 to be -$15,732,693, with the lowest ICCM earnings forecast at -$19,889,111, and the highest ICCM earnings forecast at -$10,228,686. On average, 5 Wall Street analysts forecast ICCM's earnings for 2027 to be -$11,592,510, with the lowest ICCM earnings forecast at -$17,502,418, and the highest ICCM earnings forecast at -$8,523,905.

In 2028, ICCM is forecast to generate -$5,796,255 in earnings, with the lowest earnings forecast at -$5,568,951 and the highest earnings forecast at -$5,966,733.

What is ICCM's revenue growth forecast for 2026-2028?

(NASDAQ: ICCM) Icecure Medical's forecast annual revenue growth rate of 96.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Icecure Medical's revenue in 2026 is $3,565,000.On average, 5 Wall Street analysts forecast ICCM's revenue for 2026 to be $545,529,902, with the lowest ICCM revenue forecast at $397,944,581, and the highest ICCM revenue forecast at $825,195,157. On average, 5 Wall Street analysts forecast ICCM's revenue for 2027 to be $1,113,221,957, with the lowest ICCM revenue forecast at $606,414,936, and the highest ICCM revenue forecast at $1,726,293,657.

In 2028, ICCM is forecast to generate $2,310,221,721 in revenue, with the lowest revenue forecast at $1,758,278,595 and the highest revenue forecast at $2,872,474,712.

What is ICCM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ICCM) forecast ROA is 49.8%, which is higher than the forecast US Medical Devices industry average of 14.55%.

What is ICCM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ICCM price target, the average ICCM price target is $1.00, with the highest ICCM stock price forecast at $1.00 and the lowest ICCM stock price forecast at $1.00.

The Wall Street analyst predicted that Icecure Medical's share price could reach $1.00 by May 14, 2027. The average Icecure Medical stock price prediction forecasts a potential upside of 323.73% from the current ICCM share price of $0.24.

What is ICCM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ICCM) Icecure Medical's current Earnings Per Share (EPS) is -$0.24. On average, analysts forecast that ICCM's EPS will be -$0.19 for 2026, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.13. On average, analysts forecast that ICCM's EPS will be -$0.14 for 2027, with the lowest EPS forecast at -$0.22, and the highest EPS forecast at -$0.11. In 2028, ICCM's EPS is forecast to hit -$0.07 (min: -$0.07, max: -$0.07).

What is ICCM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ICCM) forecast ROE is 77.99%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.